Renal Cancer - Results from #120

Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast. October 3, 2024

Tumor Characteristics Associated With Preoperatively Detectable Tumor-Informed Circulating Tumor DNA in Patients With Renal Masses Suspicious for Renal Cell Carcinoma. October 2, 2024

Pembrolizumab-Induced Myasthenia Gravis With Myocarditis in the Setting of Metastatic Renal Cell Carcinoma. October 2, 2024

Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses. October 1, 2024

Multi-sequence MRI-based radiomics model to preoperatively predict the WHO/ISUP grade of clear Cell Renal Cell Carcinoma: a two-center study. October 1, 2024

Imaging in Renal Cell Carcinoma Detection. September 30, 2024

The immunotherapy-based combination associated score as a robust predictor for outcome and response to combination of immunotherapy and VEGF inhibitors in renal cell carcinoma. September 30, 2024

EVEREST: Attempting the Summit with Adjuvant Everolimus To Treat High-risk Renal Cell Carcinoma After Surgery. September 29, 2024

Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study. September 29, 2024

Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma. September 27, 2024

Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129. September 27, 2024

Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review. September 27, 2024

Renal Cell Carcinoma with a Catastrophic Thrombus: A Case Report. September 27, 2024

Evaluating the Impact of a Shared Decision-making Intervention for Patients with Renal Cell Carcinoma: The SDM-RCC Study Protocol. September 26, 2024

Prognostic models for predicting oncological outcomes after surgical resection of a nonmetastatic renal cancer: A critical review of current literature. September 26, 2024

Clinical Impact of the CARMENA Trial on Cytoreductive Nephrectomy Practices in the USA: A Difference-in-differences Analysis. September 25, 2024

CT-Guided Online Adaptive Radiotherapy Delivered via Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for a Bulky Thoracic and Abdominal Mass in Oligometastatic Renal Cell Carcinoma. September 25, 2024

Development and validation of a CT based radiomics nomogram for preoperative prediction of ISUP/WHO grading in renal clear cell carcinoma. September 24, 2024

Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma. September 24, 2024

Renal Mass Biopsy is Associated With Fewer Radical Nephrectomies for Benign or Indolent Disease, Particularly for T1b Renal Masses. September 23, 2024

Page 7 of 456